g10 fx
Deutsche Bank cuts Xenon Pharmaceuticals stock rating on safety concerns By Investing.com - Investing.com Nigeria
From the original
Deutsche Bank cuts Xenon Pharmaceuticals stock rating on safety concerns By Investing.com Investing.com Nigeria
Related speeches
4 itemsDeutsche Bank bearish on Lundbeck as Rexulti faces mounting headwinds By Investing.com - Investing.com Nigeria
Deutsche Bank upgrades AstraZeneca stock rating to hold on trial results - Investing.com Nigeria
Morgan Stanley downgrades Novo Nordisk stock rating on growth concerns By Investing.com - Investing.com Nigeria
Morgan Stanley cuts Novo Nordisk on growth, patent cliff concerns; shares dip - Investing.com Nigeria
More like this
5 itemsDeutsche Bank sees dollar decline continuing on FX outlook By Investing.com - Investing.com Australia
Euro US Dollar (EUR USD) News - Investing.com
Deutsche Bank explains why Volkswagen’s 1% margin isn’t the key message By Investing.com - Investing.com South Africa
Deutsche Bank starts bullish coverage on Vincorion on defense demand, new products By Investing.com - Investing.com South Africa